Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-arm study of A0003 eye drops in cystinosis
jRCTs031220490Recruiting
- Sponsor
- National Center for Global Health and Medicine
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cysteamine in cystinosis, sponsored by National Center for Global Health and Medicine. Primary endpoint: Luminance waveform analysis (LWA) by AS-OCT. Started Dec 2022; status: recruiting.
02
Drugs
cysteamine
03
Conditions
cystinosis
Beyond the preview
Go deeper on jRCTs031220490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220490.